Background/aim: Fractionated stereotactic radiotherapy (FSRT) is a new treatment for brain tumours that are close to critical structures, such as the visual apparatus. This study aims to assess the visual outcomes for...Background/aim: Fractionated stereotactic radiotherapy (FSRT) is a new treatment for brain tumours that are close to critical structures, such as the visual apparatus. This study aims to assess the visual outcomes for patients with parasellar meningioma following FSRT. Methods: A retrospective, non-comparative case series of 13 patients with parasellar meningiomas who were treated in one institution with FSRT between January 1995 and January 2001. Results: 13 patients (26 eyes) were followed for amean of 2 years. Visual acuity improved in four eyes (12.5% ), remained stable in 18 eyes (75% ), and worsened in three eyes (12.5% ). Visual field improved in 15 eyes (57% ), remained stable in six eyes (23% ), and worsened in four eyes (15% ). No adverse visual outcome occurred as a result of radiation. Conclusion: These preliminary findings suggest that FSRT is a safe and effective treatment for parasellar meningiomas.展开更多
文摘Background/aim: Fractionated stereotactic radiotherapy (FSRT) is a new treatment for brain tumours that are close to critical structures, such as the visual apparatus. This study aims to assess the visual outcomes for patients with parasellar meningioma following FSRT. Methods: A retrospective, non-comparative case series of 13 patients with parasellar meningiomas who were treated in one institution with FSRT between January 1995 and January 2001. Results: 13 patients (26 eyes) were followed for amean of 2 years. Visual acuity improved in four eyes (12.5% ), remained stable in 18 eyes (75% ), and worsened in three eyes (12.5% ). Visual field improved in 15 eyes (57% ), remained stable in six eyes (23% ), and worsened in four eyes (15% ). No adverse visual outcome occurred as a result of radiation. Conclusion: These preliminary findings suggest that FSRT is a safe and effective treatment for parasellar meningiomas.
